Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Current Opinion in Investigational Drugs (London, England : 2000)|December 31, 2010
Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapiesDamien Pearse, Kurt JarnaginBiochemical Pharmacology|April 4, 2021
Animal models for SARS-Cov2/Covid19 research-A commentaryKurt Jarnagin, Oscar Alvarez, Sujan Shresta, et al.Toxicologic Pathology|April 29, 2006
NSAID-induced acute phase response is due to increased intestinal permeability and characterized by early and consistent alterations in hepatic gene expressionStuart Tugendreich, Cecelia I Pearson, John Sagartz, et al.Toxicologic Pathology|October 22, 2005
A gene expression signature that predicts the future onset of drug-induced renal tubular toxicityMark R Fielden, Barrett P Eynon, Georges Natsoulis, et al.Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Differential Distribution of Bradykinin B(2) Receptors in the Rat and Human Cardiovascular SystemCarlos D. Figueroa, Alejandra Marchant, Ulises Novoa, et al.Journal of Drugs in Dermatology : JDD|April 7, 2016
Crisaborole Topical Ointment, 2%: A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic DermatitisKurt Jarnagin, Sanjay Chanda, Dina Coronado, et al.Neurology|July 11, 2018
Considerations for development of therapies for cutaneous neurofibromaSharad K Verma, Vincent M Riccardi, Scott R Plotkin, et al.Biochemical Pharmacology|March 4, 2023
A precisely humanized FCRN transgenic mouse for preclinical pharmacokinetics studiesChristopher M Conner, Don van Fossan, Kristen Read, et al.Neurology|July 11, 2018
Clinical trial design for cutaneous neurofibromasAshley Cannon, Kurt Jarnagin, Bruce Korf, et al.Frontiers in Pharmacology|February 16, 2026
A new Jun amino-terminal kinase inhibitor, KRev-202, inhibits rat ischemic acute injury and the progression to renal fibrosisDavid J Nikolic-Paterson, Greg H Tesch, Elyce Ozols, et al.Pageof 3